American Pharma Pauses Trials of Potential COVID-19 Treatment

American Pharmaceutical company, Eli Lilly, which was running trials of a potential "antibody treatment" for COVID-19 has paused its trials. Reportedly, the trials were approved by the US Government and the treatment was based on the use of "monoclonal antibodies". Reports suggest that the trial was paused owing to "potential safety concerns". Though the company confirmed the news, it did not reveal the exact cause.